Biosig Technologies PE Ratio 2012-2024 | BSGM
Current and historical p/e ratio for Biosig Technologies (BSGM) from 2012 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Biosig Technologies PE ratio as of October 07, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Biosig Technologies PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-06-11 | 0.47 | 0.00 | |
| 2024-06-30 | 0.47 | $-1.26 | 0.00 |
| 2024-03-31 | 0.66 | $-2.56 | 0.00 |
| 2023-12-31 | 4.75 | $-3.40 | 0.00 |
| 2023-09-30 | 4.89 | $-4.80 | 0.00 |
| 2023-06-30 | 12.50 | $-5.60 | 0.00 |
| 2023-03-31 | 11.40 | $-5.50 | 0.00 |
| 2022-12-31 | 4.20 | $-4.30 | 0.00 |
| 2022-09-30 | 6.40 | $-2.90 | 0.00 |
| 2022-06-30 | 6.58 | $-1.50 | 0.00 |
| 2022-03-31 | 11.50 | $-2.40 | 0.00 |
| 2021-12-31 | 22.30 | $-5.00 | 0.00 |
| 2021-09-30 | 29.80 | $-8.10 | 0.00 |
| 2021-06-30 | 38.60 | $-11.90 | 0.00 |
| 2021-03-31 | 43.10 | $-16.70 | 0.00 |
| 2020-12-31 | 39.00 | $-18.70 | 0.00 |
| 2020-09-30 | 49.30 | $-22.50 | 0.00 |
| 2020-06-30 | 72.00 | $-21.20 | 0.00 |
| 2020-03-31 | 41.90 | $-17.80 | 0.00 |
| 2019-12-31 | 59.20 | $-16.50 | 0.00 |
| 2019-09-30 | 82.50 | $-9.60 | 0.00 |
| 2019-06-30 | 93.90 | $-7.10 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.005B | $0.000B |
| BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals. The Company's first product, PURE EP (tm) System, is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $228.666B | 27.41 |
| Intuitive Surgical (ISRG) | United States | $171.263B | 96.97 |
| Alcon (ALC) | Switzerland | $47.978B | 33.77 |
| IQVIA Holdings (IQV) | United States | $41.900B | 23.74 |
| Edwards Lifesciences (EW) | United States | $39.451B | 25.29 |
| IDEXX Laboratories (IDXX) | United States | $39.315B | 47.29 |
| DexCom (DXCM) | United States | $27.294B | 38.92 |
| STERIS (STE) | Ireland | $22.782B | 26.58 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.950B | 0.00 |
| Waters (WAT) | United States | $20.926B | 31.20 |
| Hologic (HOLX) | United States | $18.638B | 20.26 |
| Sysmex ADR (SSMXY) | Japan | $12.525B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.147B | 13.62 |
| Teleflex (TFX) | United States | $11.270B | 17.52 |
| Globus Medical (GMED) | United States | $9.568B | 26.76 |
| Penumbra (PEN) | United States | $7.564B | 78.52 |
| Masimo (MASI) | United States | $7.385B | 39.55 |
| Glaukos (GKOS) | United States | $7.197B | 0.00 |
| TransMedics (TMDX) | United States | $4.636B | 198.53 |
| Integer Holdings (ITGR) | United States | $4.329B | 25.32 |
| PROCEPT BioRobotics (PRCT) | United States | $3.773B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.923B | 17.14 |
| Tandem Diabetes Care (TNDM) | United States | $2.735B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.599B | 16.17 |
| Elekta AB (EKTAY) | Sweden | $2.596B | 21.15 |
| Veracyte (VCYT) | United States | $2.523B | 156.38 |
| Inari Medical (NARI) | United States | $2.443B | 0.00 |
| RxSight (RXST) | United States | $1.809B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.319B | 6.01 |
| Artivion (AORT) | United States | $1.108B | 101.69 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.066B | 19.02 |
| OPKO Health (OPK) | United States | $1.039B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.979B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.771B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.723B | 18.25 |
| IRadimed (IRMD) | United States | $0.631B | 34.12 |
| OrthoPediatrics (KIDS) | United States | $0.628B | 0.00 |
| SiBone (SIBN) | United States | $0.612B | 0.00 |
| AxoGen (AXGN) | United States | $0.599B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.584B | 0.00 |
| Paragon 28 (FNA) | United States | $0.491B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.469B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.343B | 10.47 |
| Treace Medical Concepts (TMCI) | United States | $0.332B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.309B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.292B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.248B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.244B | 0.00 |
| Inogen (INGN) | United States | $0.216B | 0.00 |
| NeuroPace (NPCE) | United States | $0.199B | 0.00 |
| Accuray (ARAY) | United States | $0.192B | 0.00 |
| CVRx (CVRX) | United States | $0.191B | 0.00 |
| Nevro (NVRO) | United States | $0.185B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.185B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.175B | 12.25 |
| Alpha Tau Medical (DRTS) | Israel | $0.159B | 0.00 |
| 908 Devices (MASS) | United States | $0.121B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.120B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.119B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.103B | 15.34 |
| EDAP TMS S.A (EDAP) | France | $0.098B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.066B | 0.00 |
| Envoy Medical (COCH) | United States | $0.065B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.063B | 0.00 |
| LENSAR (LNSR) | United States | $0.052B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.046B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.044B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.043B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.039B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| DarioHealth (DRIO) | United States | $0.034B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.034B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.032B | 0.00 |
| Precision Optics (POCI) | United States | $0.030B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.028B | 0.00 |
| Neuronetics (STIM) | United States | $0.026B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.019B | 0.00 |
| Spectral AI (MDAI) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |